Thinking of Offshoring Your ADME Screening Services?

Selecting the right partner for ADME services is a key component of an effective drug discovery partnership.

With projections that over the next 4-5 years almost half of drug discovery will be outsourced, biopharma companies are working hard to find the right partner to deliver comprehensive PK/PD and ADME support. With ever-growing pressure to deliver more data with fewer resources, that search may include ADME service providers based in low cost regions such as China or India. While the initial pricing considerations may be appealing, our customers often recount that there are significant advantages to choosing a more local partner. Q2 Solutions offers complete bioanalytical and ADME solutions for testing around the globe and across the product development spectrum.

Download this insight brief to learn about key factors to consider when thinking about offshoring your ADME screening services.

Shelby Anderson, Ph.D.

Complete the form below to access this insight brief